
How to Choose the Right CRO for Your IVD or Medical Device Study
Selecting a reliable Clinical Research Organization (CRO) is a pivotal step for healthcare professionals and doctors involved in in vitro diagnostic (IVD) or medical device

Selecting a reliable Clinical Research Organization (CRO) is a pivotal step for healthcare professionals and doctors involved in in vitro diagnostic (IVD) or medical device

In today’s fast-evolving healthcare landscape, diagnostic tools are advancing to meet the increasing demands for speed, accessibility, and accuracy. Two such categories—Over-the-Counter (OTC) and Point-of-Care

The field of in vitro diagnostics (IVDs) is one of the fastest-evolving sectors in healthcare. With advances in genomics, digital diagnostics, and regulatory science, staying

In the fast-paced and highly regulated world of healthcare, clinicians and procurement specialists must ensure that the medical products they use meet the highest standards

In vitro diagnostics (IVDs) have long played a vital role in modern healthcare, offering the precision and speed needed to detect, monitor, and manage diseases.

Operating from the heart of the life sciences sector, Acenth collaborates with Clinical Research Organization (CRO) professionals to better understand the frameworks that support the

In vitro diagnostics (IVDs) are foundational to modern medicine. From genetic panels and infectious disease assays to cancer biomarkers and routine blood tests, IVDs inform

As medical technologies rapidly evolve, the clinical environment has become more reliant on advanced devices—from robotic surgical tools and implantable monitors to AI-driven diagnostics. For

The U.S. Food and Drug Administration (FDA) plays a foundational role in overseeing clinical research involving drugs, biologics, and medical devices. For healthcare professionals and

Medical product labeling serves as a critical conduit between manufacturers, regulators, and healthcare providers. For clinicians and researchers, the label is not just packaging—it’s a